Rhenman & Partners Asset Management’s Hologic HOLX Stock Holding History

Rhenman & Partners Asset Management’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-70,000	Closed	-$3.18M	–	101
2017 Q2	$3.18M	Sell	70,000 -80,000	-53%	-$3.53M	0.46%	70
2017 Q1	$6.38M	Sell	150,000 -10,000	-6%	-$408K	1.01%	38
2016 Q4	$6.42M	Sell	160,000 -20,000	-11%	-$772K	1.23%	31
2016 Q3	$6.99M	Hold	180,000	–	–	1.11%	31
2016 Q2	$6.23M	Buy	180,000 +120,000	+200%	+$4.16M	1.11%	31
2016 Q1	$2.07M	Buy	60,000 +26,699	+80%	+$931K	0.41%	75
2015 Q4	$1.29M	Hold	33,301	–	–	0.19%	93
2015 Q3	$1.3M	Sell	33,301 -59,699	-64%	-$2.37M	0.21%	88
2015 Q2	$3.54M	Sell	93,000 -8,000	-8%	-$280K	0.43%	76
2015 Q1	$3.34M	Buy	101,000 +7,000	+7%	+$215K	0.56%	58
2014 Q4	$2.51M	Buy	94,000 +4,000	+4%	+$103K	0.73%	59
2014 Q3	$2.19M	Buy	90,000 +17,000	+23%	+$429K	0.64%	58
2014 Q2	$1.85M	Buy	+73,000	New	+$1.71M	0.55%	66
2014 Q1	–	Sell	-72,000	Closed	-$1.61M	–	93
2013 Q4	$1.61M	Buy	+72,000	New	+$1.59M	0.63%	69

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Rhenman & Partners Asset Management's HOLX Position: Q3 2017 in Review

Rhenman & Partners Asset Management sold out of Hologic (HOLX) in Q3 2017, closing a stake of 70,000 shares — an estimated $3.18M sold.

Rhenman & Partners Asset Management first reported a position in HOLX in Q4 2013 and held it in 14 quarters. The position peaked at $6.99M in Q3 2016. 457 funds tracked by Wall St. Rank hold HOLX as of Q3 2017.

Rhenman & Partners Asset Management reported no remaining Hologic position as of Q3 2017 after selling out during the quarter.
Rhenman & Partners Asset Management sold 70,000 Hologic shares in Q3 2017, an estimated $3.18M.
Rhenman & Partners Asset Management first reported a position in Hologic in Q4 2013 and held it in 14 quarters.
Rhenman & Partners Asset Management's Hologic position peaked at $6.99M in Q3 2016.
457 funds tracked by Wall St. Rank held Hologic as of Q3 2017.

Based on Rhenman & Partners Asset Management's 13F filing for Q3 2017, filed 13 Oct 2017.